Pines Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.72M Sell
4,765
-50
-1% -$51.1K 1.64% 11
2026
Q1
$4.43M Buy
4,815
+62
+1% +$62.9K 1.43% 16
2025
Q4
$5.11M Buy
4,753
+102
+2% +$97.5K 1.65% 15
2025
Q3
$3.55M Buy
4,651
+281
+6% +$209K 1.2% 17
2025
Q2
$3.41M Buy
4,370
+291
+7% +$226K 1.21% 16
2025
Q1
$2.96M Buy
4,079
+530
+15% +$441K 1.37% 16
2024
Q4
$2.84M Buy
+3,549
New +$2.94M 1.24% 18

Other funds holding LLY

Pines Wealth Management's LLY Position: Q2 2026 in Review

Pines Wealth Management reduced its Eli Lilly (LLY) stake by 1% in Q2 2026, selling an estimated $51.1K and leaving 4,765 shares worth $5.72M. The position accounts for 1.64% of the portfolio, ranked #11.

Pines Wealth Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pines Wealth Management held 4,765 shares of Eli Lilly worth $5.72M as of Q2 2026.
  • Pines Wealth Management sold 50 Eli Lilly shares in Q2 2026, an estimated $51.1K.
  • Eli Lilly made up 1.64% of Pines Wealth Management's portfolio in Q2 2026, its #11 holding.
  • Pines Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pines Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.